(R)-3-octanoyloxytetradecanoic acid | 216013-06-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (R)-3-octanoyloxytetradecanoic acid
• 英文别名: (3R)-3-octanoyloxytetradecanoic acid
• CAS: 216013-06-8
• 化学式: C₂₂H₄₂O₄
• 分子量: 370.573
• InChiKey: HYSAWPWQMOQSDC-HXUWFJFHSA-N

物化性质

• 沸点：
  478.9±28.0 °C(Predicted)
• 密度：
  0.949±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  8.3
• 重原子数：
  26
• 可旋转键数：
  20
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (R)-3-octanoyloxytetradecanoic acid 在 EDC.MeI 作用下， 以 二氯甲烷 为溶剂， 以1.02 g (93%)的产率得到N-[(R)-3-octanoyloxytetradecanoyl]-L-serine benzyl ester
  参考文献：
  名称：

  Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors

  摘要：

  描述和声明了一种作为辅助剂和免疫效应物的氨基糖脂磷酸酯（AGP）化合物。这些化合物具有一个2-脱氧-2-氨基葡萄糖与一个氨基烷基（糖苷）基团的糖苷键连接。这些化合物在葡萄糖氨基环上的4或6碳上磷酸化，并包括三个3-烷酰氧烷酰基。这些化合物增强了免疫动物中的抗体产生，同时刺激细胞因子的产生并激活巨噬细胞。还公开了将这些化合物用作辅助剂和免疫效应物的组合物和方法。

  公开号：

  US20030092643A1
• 作为产物：
  描述：

  2-(4-bromophenyl)-2-oxoethyl (R)-3-hydroxytetradecanoate 、 辛酰氯 在 吡啶 、 锌 作用下， 以 二氯甲烷 、 溶剂黄146 为溶剂， 生成 (R)-3-octanoyloxytetradecanoic acid
  参考文献：
  名称：

  Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors

  摘要：

  描述和声明了一种氨基糖胺磷酸盐化合物，它们是辅助剂和免疫效应物质。这些化合物具有一个2-脱氧-2-氨基葡萄糖与一个氨基烷基（非糖部分）基团的糖苷键连接。这些化合物在葡萄糖胺环上的4或6碳上磷酸化，并包括三个3-烷酰氧烷酰残基。这些化合物增强了免疫动物中的抗体产生，同时刺激细胞因子的产生并激活巨噬细胞。还公开了将这些化合物用作辅助剂和免疫效应物质的方法。

  公开号：

  US06355257B1

文献信息

• Aminoalkyl glucosamine phosphate compounds and their use as adjuvants
  申请人：Ribi ImmunoChem Research, Inc.

  公开号：US06113918A1

  公开（公告）日：2000-09-05

  Aminoalkyl glucosamine phosphate compounds that are adjuvants and immunoeffectors are described and claimed. The compounds have a 2-deoxy-2-amino glucose in glycosidic linkage with an aminoalkyl (aglycon) group. Compounds are phosphorylated at the 4 or 6 carbon on the glucosamine ring and comprise three 3-alkanoyloxyalkanoyl residues. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Methods for using the compounds as adjuvants and immunoeffectors are also disclosed.

  描述并声明了一种氨基糖氨磷酸化合物，用作辅助剂和免疫效应物质。这些化合物在糖苷键中含有2-脱氧-2-氨基葡萄糖与氨基烷基（缺糖原）基团。这些化合物在葡萄糖胺环上的第4或第6碳上磷酸化，并包括三个3-烷酰氧烷酰残基。这些化合物增强了免疫动物中的抗体产生，同时刺激细胞因子的产生并激活巨噬细胞。还公开了使用这些化合物作为辅助剂和免疫效应物质的方法。
• [EN] AMINOALKYL GLUCOSAMINE PHOSPHATE COMPOUNDS AND THEIR USE AS ADJUVANTS AND IMMUNOEFFECTORS<br/>[FR] COMPOSES D'AMINOALKYLE GLUCOSAMINE PHOSPHATES ET LEUR UTILISATION COMME ADJUVANTS ET IMMUNOEFFECTEURS
  申请人：CORIXA CORPORATION

  公开号：WO1998050399A1

  公开（公告）日：1998-11-12

  (EN) Aminoalkyl glucosamine phosphate compounds that are adjuvants and immunoeffectors are described and claimed. The compounds have a 2-deoxy-2-amino glucose in glycosidic linkage with an aminoalkyl (aglycon) group. Compounds are phosphorylated at the 4 or 6 carbon on the glucosamine ring and comprise three 3-alkanoyloxyalkanoyl residues. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Methods for using the compounds as adjuvants and immunoeffectors are also disclosed.(FR) La présente invention concerne des composés d'aminoalkyle glucosamine phosphates qui sont des adjuvants et des immunoeffecteurs. Ces composés ont un 2-désoxy-2-aminoglucose en liaison glucidique avec un groupe aminoalkyle (aglycon). Ces composés sont phosphorylés au niveau du carbone 4 ou 6 sur le noyau de glucoseamine et comprennent trois résidus 3-alcanoyloxyalcanoyle. Les composés augmentent la production d'anticorps chez des animaux immunisés, stimulent la production de cytokine et activent des macrophages. La présente invention concerne également des procédés d'utilisation de ces composés comme adjuvants et immunoeffecteurs.

  (中文) 描述并声明了一种作为辅助剂和免疫效应物质的氨基糖磷酸化合物。这些化合物在糖苷键上具有2-去氧-2-氨基葡萄糖和氨基烷基（脱糖基）基团。化合物在葡萄糖胺环上的4或6碳处磷酸化，并包括三个3-烷酰氧基烷酰基残基。这些化合物增强了免疫动物中的抗体产生，同时刺激细胞因子的产生和激活巨噬细胞。还公开了使用这些化合物作为辅助剂和免疫效应物质的方法。
• ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM
  申请人：BAUER Jacques

  公开号：US20130022628A1

  公开（公告）日：2013-01-24

  The present invention is directed in particular to dipeptide-like compounds derived from functionally substituted amino acids, having fatty acid chains bound thereto through amidification of the amine functional groups of said dipeptide-like compounds, one end portion of which bears an accessory functional side chain spacer, with the other end portion being an acid group either in neutral or charged state. Compounds of the present invention have immunomodulating properties like adjuvants. In addition, compounds of the invention can be grafted on a given antigen in order to modulate or tune the immune response or can be equally grafted on a pharmaceutical carrier to enhance the therapeutic effect or targeting thereof. Accordingly, compounds of the invention find use in human and veterinary medicine both as immunogens and diagnostic tools.

  本发明特别针对从功能取代的氨基酸中衍生出来的二肽类化合物，其通过酰胺化作用将脂肪酸链结合到所述二肽类化合物的胺基官能团上，其中一端部分具有辅助功能侧链间隔物，而另一端部分是一个酸基，可以是中性或带电状态。本发明的化合物具有类似佐剂的免疫调节特性。此外，本发明的化合物可以嫁接到给定的抗原上，以调节或调整免疫反应，也可以同样嫁接到药物载体上，以增强其治疗效果或靶向性。因此，本发明的化合物在人类和兽医医学中均可用作免疫原和诊断工具。
• Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs)
  作者：David A. Johnson、C. Gregory Sowell、Craig L. Johnson、Mark T. Livesay、David S. Keegan、Michael J. Rhodes、J. Terry Ulrich、Jon R. Ward、John L. Cantrell、Valerie G. Brookshire

  DOI：10.1016/s0960-894x(99)00374-1

  日期：1999.8

  A novel series of acylated omega-aminoalkyl 2-amino-2-deoxy-4-phosphono-beta-D-glucopyranosides (aminoalkyl glucosaminide 4-phosphates) was synthesized and screened for immunostimulant activity. Several of these compounds enhance the production of tetanus toroid-specific antibodies in mice and augment vaccine-induced cytotoxic T cells against EG.7-ova target cells. (C) 1999 Elsevier Science Ltd. Pill rights reserved.
• 3-<i>O</i>-Desacyl Monophosphoryl Lipid A Derivatives:  Synthesis and Immunostimulant Activities
  作者：David A. Johnson、David S. Keegan、C. Gregory Sowell、Mark T. Livesay、Craig L. Johnson、Lara M. Taubner、Annalivia Harris、Kent R. Myers、Jennifer D. Thompson、Gary L. Gustafson、Michael J. Rhodes、J. Terry Ulrich、Jon R. Ward、Yvonne M. Yorgensen、John L. Cantrell、Valerie G. Brookshire

  DOI：10.1021/jm990222b

  日期：1999.11.1

  The synthesis of a series of novel analogues of lipid A, the active principle of lipopolysaccharide, is reported. In these compounds, the 1-O-phosphono and (R)-3-hydroxytetradecanoyl moieties of native Salmonella minnesota R595 lipid A have been replaced with hydrogen and the length of the normal fatty acyl residues has been systematically varied. Normal fatty acid chain length in the 3-O-desacyl monophosphoryl lipid A (MLS) series is shown to be a critical determinant of iNOS gene expression in activated mouse macrophages and the induction of proinflammatory cytokines in human peripheral monocytes. Examination of pyrogenicity in rabbits and lethal toxicity in D-galactosamine-treated mice shows that toxic effects in the MLA series can be ameliorated by modifying fatty acid chain length. When used as an adjuvant for tetanus toroid vaccines, certain MLA derivatives enhance the production of tetanus toroid-specific antibodies in mice.